Engineering Size‐Controlled Erythrocyte‐Derived Particles for NIR‐Responsive Theranostic Applications in Oropharyngeal Carcinoma
Chemistry – An Asian Journal · 2026
DOI: 10.1002/asia.70677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2026. Verfasst von Sarmistha Mazumder und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Technology Centre, Indian Institute of Technology, Jodhpur, Rajasthan, India. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Oropharyngeal Neoplasms, Indocyanine Green, Erythrocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: IIT Jodhpur, SERB, Ministry of Ayush.
Abstract (Originalsprache)
Erythrocyte membranes, also known as ghosts, can be utilized as drug carriers or camouflaging membranes for drug delivery systems due to their “self‐to‐biological system” nature. However, size modulation of erythrocyte ghosts may influence their drug loading capabilities, cellular uptake, and performance as drug carriers. Herein, we have prepared micron‐sized N ear i nfrared E rythrocyte P articles (µNiEP) and nanosized variants (NiEP 400 , NiEP 100 ) erythrocyte‐derived particles using whole human blood and encapsulated with a near infrared fluorophore, indocyanine green (ICG). Size modulation of ICG‐loaded erythrocyte ghosts is achieved through hypotonic lysis and regulated extrusion. Physico‐chemical characterization confirms preservation of specific membrane proteins, including CD47, indicating immune evasion abilities across all three formulations. Size‐dependent cellular uptake studies in Detroit‐562 oropharyngeal cancer cells reveal that NiEP 100 demonstrates superior penetration and intracellular distribution. NIR laser‐mediated photothermal studies unveil NiEP 100 showing uptake‐correlated cytotoxicity enhancement (∼1.8‐fold). NiEP 400 shows limited therapeutic benefit (∼0.9‐fold) with moderate uptake. All displayed macrophage evasion through inherent biomimetic properties. These findings establish a vital size‐performance relationship for erythrocyte‐based particles. This study provides a foundation for developing optimized, patient‐tailored cancer therapeutic platforms with enhanced therapeutic indices and clinical translation potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Technology Centre, Indian Institute of Technology, Jodhpur, Rajasthan, India.
- Department of Radiation Oncology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
- Department of Bioscience & Bioengineering, Indian Institute of Technology, Jodhpur, Rajasthan, India.
ORCID-Profile: Raviraj Vankayala
Förderung
- IIT Jodhpur
- SERB
- Ministry of Ayush
- Science and Engineering Research Board
Zitieren
APA
Mazumder, S., Pareek, P., & Vankayala, R. (2026). Engineering Size‐Controlled Erythrocyte‐Derived Particles for NIR‐Responsive Theranostic Applications in Oropharyngeal Carcinoma. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.70677
Vancouver
Mazumder S, Pareek P, Vankayala R. Engineering Size‐Controlled Erythrocyte‐Derived Particles for NIR‐Responsive Theranostic Applications in Oropharyngeal Carcinoma. Chemistry – An Asian Journal. 2026. doi:10.1002/asia.70677
BibTeX
@article{Mazumder2026,
author = {Mazumder, Sarmistha and Pareek, Puneet and Vankayala, Raviraj},
title = {Engineering Size‐Controlled Erythrocyte‐Derived Particles for NIR‐Responsive Theranostic Applications in Oropharyngeal Carcinoma},
journal = {Chemistry – An Asian Journal},
year = {2026},
doi = {10.1002/asia.70677}
}
EUVIMED